ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET

IQ-AI Limited.
43 announcements.
Time Date Ticker Company Announcement
07:00 20-11-2024 IQAI IQ-AI Limited
Imaging Biometrics Expands Distribution
11:27 19-11-2024 IQAI IQ-AI Limited
Board Changes
07:00 05-11-2024 IQAI IQ-AI Limited
New Patent Application and Trading Update
12:08 14-10-2024 IQAI IQ-AI Limited
Holding(s) in Company
12:05 14-10-2024 IQAI IQ-AI Limited
PDMR dealing and TR1 announcement
10:42 11-10-2024 IQAI IQ-AI Limited
Acquisition of Interest by Braveheart
09:59 25-06-2024 IQAI IQ-AI Limited
IB Opens Expanded Access Program
08:38 14-06-2024 IQAI IQ-AI Limited
Clinical Trial Updates
15:08 29-05-2024 IQAI IQ-AI Limited
Result of AGM
07:00 23-05-2024 IQAI IQ-AI Limited
Major East Coast Health System Chooses IB Nimble
07:00 17-05-2024 IQAI IQ-AI Limited
IB Software Enhances Clinical Decision-Making
08:15 10-05-2024 IQAI IQ-AI Limited
Rare Pediatric Disease Designation Granted to GaM
12:47 02-05-2024 IQAI IQ-AI Limited
IB Announces Expanded Access Program for GaM
15:26 29-04-2024 IQAI IQ-AI Limited
Publication of Annual Report
07:00 05-03-2024 IQAI IQ-AI Limited
Grant of Options
08:20 01-03-2024 IQAI IQ-AI Limited
Holding(s) in Company
08:22 01-03-2024 IQAI IQ-AI Limited
Holding(s) in Company
07:00 26-02-2024 IQAI IQ-AI Limited
Result of Broker Option and Total Voting Rights
07:00 22-02-2024 IQAI IQ-AI Limited
Placing and Broker Option
12:49 09-02-2024 IQAI IQ-AI Limited
FDA Application Update
08:39 02-02-2024 IQAI IQ-AI Limited
IB awarded a $100,000 grant
10:05 22-01-2024 IQAI IQ-AI Limited
Holding(s) in Company
07:00 15-01-2024 IQAI IQ-AI Limited
Holding(s) in Company
07:01 15-01-2024 IQAI IQ-AI Limited
Director Dealings and Conversion of CLNs
07:00 10-01-2024 IQAI IQ-AI Limited
IB Launching an Expanded Access Program for GaM
14:29 19-12-2023 IQAI IQ-AI Limited
Imaging Biometrics granted FDA “Fast-Track”
10:58 05-12-2023 IQAI IQ-AI Limited
IQ-AI Announces Positive Interim Phase 1 Results
13:42 20-11-2023 IQAI IQ-AI Limited
Holding(s) in Company
11:38 09-11-2023 IQAI IQ-AI Limited
Director Dealing and Conversion of CLNs
10:59 08-11-2023 IQAI IQ-AI Limited
Application for Pediatric Rare Disease Designation
13:02 06-11-2023 IQAI IQ-AI Limited
Holding(s) in Company
14:29 18-10-2023 IQAI IQ-AI Limited
Update Regarding Imaging Biometrics LLC
08:55 13-10-2023 IQAI IQ-AI Limited
IB Letter to Shareholders
07:00 09-10-2023 IQAI IQ-AI Limited
Orphan Drug Status to GaM and Total Voting Rights
11:30 03-10-2023 IQAI IQ-AI Limited
Holding(s) in Company
14:32 19-09-2023 IQAI IQ-AI Limited
IQ-AI shares cease trading on the OTCQB
07:00 08-09-2023 IQAI IQ-AI Limited
Reduced Gadolinium Approach Validated'
12:06 18-08-2023 IQAI IQ-AI Limited
Update on Collaboration Agreement with Mayo Clinic
11:20 18-08-2023 IQAI IQ-AI Limited
IB & GE HealthCare Enter into Commercial Agreement
07:00 17-08-2023 IQAI IQ-AI Limited
Half-year Report
07:00 13-07-2023 IQAI IQ-AI Limited
Orphan Drug Designation for GaM in Pediatric GBM
11:02 23-05-2023 IQAI IQ-AI Limited
Result of AGM
07:00 23-05-2023 IQAI IQ-AI Limited
AGM Statement